Indegene Reports ₹102.1 Crore Net Profit in Q2 FY26; Revenue Up 17.1%

Indegene, a healthcare technology firm, announced its financial results for the quarter ended September 2025, reporting strong revenue growth and improved profitability despite margin pressures.

Financial Highlights

• Net Profit: ₹102.1 crore, up 11.34% YoY from ₹91.7 crore
• Revenue from Operations: ₹804.2 crore, up 17.1% YoY from ₹686.8 crore
• EBITDA: ₹140.8 crore, up 11.7% YoY from ₹126.1 crore
• Operating Margin:5%, down from 18.4% in Q2 FY25

The decline in operating margin reflects cost pressures, even as revenue and EBITDA posted healthy growth.

Strategic Investment in Subsidiary

Indegene announced an investment in its wholly owned subsidiary, Indegene Ireland Ltd, to support capital expenditure for business expansion. The investment will be completed by December 31, 2026, through subscription to equity shares at a premium determined by a registered valuer.

Subsidiary Performance

Indegene Ireland Ltd provides analytics, technology, and regulatory solutions to life sciences and healthcare organisations. For FY25, the subsidiary reported a turnover of €739,163, compared to €596,780 in FY24 and €477,388 in FY23, indicating consistent growth.

Indegene Share Price Performance

On October 31, 2025, Indegene share price opened at ₹555.85, compared to the previous close of ₹552.05. During the session, the stock touched a high of ₹556.40 and a low of ₹534.00. At 12:57 PM IST, it was trading at ₹538.80, down by 2.40%.

The stock recorded a traded volume of 3.29 lakh shares and a traded value of ₹17.77 crore on the NSE. The market capitalisation stood at ₹12,938.72 crore. Over the past 52 weeks, Indegene has hit a high of ₹735.00 and a low of ₹499.00. The stock is currently trading at a P/E ratio of 30.45.

Read More: Cipla Plans Seven New Product Launches by 2026.

Conclusion

Indegene delivered strong revenue and profit growth in Q2 FY26, supported by strategic investments and subsidiary expansion. While margins faced pressure, the company’s focus on global operations and technology-driven solutions positions it for sustained growth.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.